Patents Assigned to Beijing Zhongwei Shennong Chronic Disease Medical Research Institute Co., Ltd.
  • Publication number: 20140206737
    Abstract: This invention relates to a new application of compound Clonidine Hydrochloride in a use of preparation of information intervention agent, a new preparation method of information intervention agent, and a product. The Clonidine Hydrochloride interacts with the human information receptor, therefore realizing the intervention through the Clonidine Hydrochloride information physical method, and treatment was not a chemical treatment. This invention comprises: putting the compound Clonidine Hydrochloride information package filler (3) into a container (4), closing the lid (7), sealing by a glue, attaching a hanging piece to the container (4) to form the Clonidine Hydrochloride information intervention agent (9) for clinical use. The usage of this invention is simple, convenient, safe, reliable and easy to accept. It is especially appropriate for use by senior people, unhealthy people, children, or people with disturbance of consciousness, mental retardation, and behavioral disorders.
    Type: Application
    Filed: January 21, 2013
    Publication date: July 24, 2014
    Applicant: Beijing Zhongwei Shennong Chronic Disease Medical Research Institute Co., Ltd.
    Inventor: Beijing Zhongwei Shennong Chronic Disease Medical Reasearch Institute Co., Ltd.